In this episode of ESR Connect, a world-class multidisciplinary panel of experts
will discuss the status quo of lung, breast and colorectal cancer screening programmes
in Europe, how patients were affected by the COVID-19 pandemic, and how can programmes be restarted now.
The episode will be hosted by one of the leading oncologic imagers in Europe, Regina Beets-Tan
from The Netherlands Cancer Institute, currently 1st Vice-President of ESR and a board member of ECCO (European Cancer Organisation) as well as member of the EU Cancer mission board.
professor of radiology at the Heidelberg University Hospital and the German Centre for Lung Research, will give an overview of the current recommendations for lung cancer screening he has co-published in a European expert panel last year, and why it is important to do screening the right way and under the right circumstances. He will also report on how the pandemic influenced ongoing screening programmes in different countries and how they will cope with the new circumstances.
Professor of radiology at Lund University, Sweden, Sophia Zackrisson
is one of the leading scientists in her field and will speak about the status quo of breast screening, the potential role of digital breast tomosynthesis and other imaging modalities, and if artificial intelligence can be of assistance. Zackrisson, who holds a PhD in epidemiology and has initiated several clinical and epidemiological studies in cancer imaging, will also describe Sweden’s experience with COVID-19 and discuss how breast screening programmes can be brought to full capacity again.
is a gastroenterologist at the Amsterdam University Medical Centers location AMC and a professor of gastrointestinal oncology at the University of Amsterdam. She is a world renown expert in her field and will provide insight on her research on screening methods for colorectal cancer. Dekker will also report on the effects of the COVID-crisis on the Dutch screening program for colorectal cancer, a programme for which she has been advisor for over a decade, and share the lessons taken from it for the future.
In collaboration with the European Cancer Organisation